Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, MacroGenics Inc maintains a gross margin of 84.09%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 25.59%, while the net margin is 23.09%. These profitability ratios, combined with a Return on Equity (ROE) of -81.13%, provide a clear picture of how effectively MGNX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MGNX competes directly with industry leaders such as RPTX and ADAG. With a market capitalization of $121.14M, it holds a significant position in the sector. When comparing efficiency, MGNX's gross margin of 84.09% stands against RPTX's 100.00% and ADAG's N/A. Such benchmarking helps identify whether MacroGenics Inc is trading at a premium or discount relative to its financial performance.
